CC Chemokine Receptor Type 5 Global Market Report 2025
상품코드:1703087
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 200 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
CC 케모카인 수용체 5형 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년까지 22억 7,000만 달러에 달할 것으로 예상되며, CAGR은 10.1%를 보일 것으로 예측됩니다. 예측 기간의 성장은 HIV 또는 AIDS의 확산, 의료 인프라, 경제적 인센티브, 의료 수요 증가, 경제 성장에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 암 치료 관련 연구개발 확대, 병용요법 개발, 의약품 제조 개발, 전략적 제휴 및 파트너십, 임상시험 확대 등을 들 수 있습니다.
만성 질환의 유병률 증가는 향후 몇 년 동안 CC 케모카인 수용체 5형(CCR5) 시장의 성장을 견인할 것으로 예측됩니다. 만성질환은 심장병, 당뇨병, 관절염과 같은 장기적인 질환으로 서서히 진행되어 일반적으로 지속적인 관리가 필요한 질환입니다. 만성질환 증가는 인구 고령화, 식습관 장애, 운동 부족, 비만 등 생활습관 관련 위험요인 증가에 기인하며, CCR5는 인간면역결핍바이러스(HIV)와 같은 만성질환에서 중요한 역할을 하며, 면역세포에 바이러스의 침입을 촉진하고 질병 진행에 기여하는 핵심 수용체 역할을 합니다. 질병 진행에 기여하는 핵심 수용체로 작용합니다. 예를 들어, 2023년 10월 스위스에 기반을 둔 HIV 예방에 초점을 맞춘 세계 이니셔티브인 유엔 합동 에이즈 프로그램(Joint United Nations Programme on HIV/AIDS)은 2021년에는 약 3,870만 명이 HIV에 감염될 것이며, 그 수는 2022년에는 3,900만 명으로 증가할 것이며, 그 중에는 같은 해 신규 감염자 130만 명도 포함될 것이라고 보고했습니다. 결과적으로 만성질환 유병률 증가는 CCR5 시장의 성장을 가속하고 있습니다.
CCR5 시장 기업들은 경쟁력을 유지하기 위해 CCR5 길항제와 같은 신약 개발에 집중하고 있으며, CCR5 길항제는 면역세포의 CCR5 수용체를 차단하여 HIV와 같은 특정 병원체가 세포에 결합하여 침입하는 것을 방지하여 감염을 억제하고 면역 반응에 영향을 미치는 약품입니다. 약제입니다. 예를 들어, 2024년 2월 미국 생명공학 기업 사이토다인(CytoDyn Inc.)은 미국 식품의약국(FDA)이 PRO140으로도 알려진 CCR5 길항제인 렐론리맙(leronlimab)의 임상 보류를 해제했다고 발표하였습니다. 이번 승인으로 사이토다인은 만성 염증에 대한 레론리맙의 효과를 평가하기 위해 계획했던 임상시험을 진행할 수 있게 됐습니다. 레론리맙은 여러 질병을 표적으로 삼을 수 있어 HIV와 암을 포함한 다양한 건강 상태를 치료할 수 있는 가능성을 보여주고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 CC 케모카인 수용체 5형 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 CC 케모카인 수용체 5형 시장 : 성장률 분석
세계의 CC 케모카인 수용체 5형 시장 실적 : 규모와 성장, 2019-2024
세계의 CC 케모카인 수용체 5형 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 CC 케모카인 수용체 5형 전체 시장(TAM)
제6장 시장 세분화
세계의 CC 케모카인 수용체 5형 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
BMS-813160
AG-1105
CCL-14
DS-001
기타 유형
세계의 CC 케모카인 수용체 5형 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원
클리닉
온라인 약국
소매 약국
세계의 CC 케모카인 수용체 5형 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
감염증
위장
면역학
종양학
기타 용도
세계의 CC 케모카인 수용체 5형 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
연구기관
제약회사
의료시설
세계의 CC 케모카인 수용체 5형 시장 : BMS-813160 세분화(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
HIV 치료를 위한 CCR5 길항제
염증성 질환에 대한 CCR5 길항제
세계의 CC 케모카인 수용체 5형 시장 AG-1105 세분화(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
자가면역질환에 대한 CCR5 길항제
암치료용 CCR5 길항제
세계의 CC 케모카인 수용체 5형 시장 CCL-14 세분화(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
표적치료를 위한 케모카인 리간드
면역 조절을 위한 CCL-14
세계의 CC 케모카인 수용체 5형 시장 DS-001세분화, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
암치료 CCR5 억제제
DS-001 염증성 질환 관리용
세계의 CC 케모카인 수용체 5형 시장 : 기타 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
신규 CCR5 길항제
이중 표적 CCR5 길항제
제7장 지역별/국가별 분석
세계의 CC 케모카인 수용체 5형 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 CC 케모카인 수용체 5형 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
CC 케모카인 수용체 5형 시장 : 경쟁 구도
CC 케모카인 수용체 5형 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Sorrento Therapeutics Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
Avexa Limited
Thermo Fisher Scientific Inc.
AstraZeneca plc
Novartis AG
GlaxoSmithKline plc
Takeda Pharmaceutical
Gilead Sciences Inc.
Vertex Pharmaceuticals
Ono Pharmaceutical Co Ltd
Abcam Limited
BioLegend Inc.
R&D Systems Inc
American Gene Technologies International Inc
NSJ Bioreagents
Cytodyn Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
CC 케모카인 수용체 5형 시장(2029년) : 새로운 기회를 제공하는 국가
CC 케모카인 수용체 5형 시장(2029년) : 새로운 기회를 제공하는 부문
CC 케모카인 수용체 5형 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
CC chemokine receptor type 5 (CCR5) is a protein found on the surface of white blood cells that plays a crucial role in the immune system by serving as a receptor for specific chemokines. These signaling molecules guide the movement of immune cells to areas of inflammation or infection. CCR5 is notably involved in the pathogenesis of diseases such as HIV, where it acts as a co-receptor, enabling the virus to enter and infect host cells, thus making it a target for therapeutic interventions.
The main types of CCR5-related compounds include BMS-813160, AG-1105, CCL-14, DS-001, and others. BMS-813160 is a small-molecule inhibitor developed by Bristol-Myers Squibb, designed to target specific receptors or pathways and is often investigated for its potential therapeutic effects in diseases such as cancer. Distribution channels for these compounds include hospitals, clinics, online pharmacies, and retail pharmacies. They are applied in various fields, including infectious diseases, gastrointestinal conditions, immunology, and oncology, and are used by different end-users such as research institutes, pharmaceutical companies, and healthcare facilities.
The CC chemokine receptor type 5 market research report is one of a series of new reports from The Business Research Company that provides CC chemokine receptor type 5 market statistics, including CC chemokine receptor type 5 industry global market size, regional shares, competitors with an CC chemokine receptor type 5 market share, detailed CC chemokine receptor type 5 market segments, market trends, and opportunities, and any further data you may need to thrive in the CC chemokine receptor type 5 industry. This CC chemokine receptor type 5 market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The CC chemokine receptor type 5 market size has grown rapidly in recent years. It will grow from $1.4 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to government funding, R&D collaborations, public health campaigns, public-private partnerships, and the discovery of CCR5.
The CC chemokine receptor type 5 market size is expected to see rapid growth in the next few years. It will grow to $2.27 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to the prevalence of HIV or AIDS, healthcare infrastructure, economic incentives, increasing demand for healthcare, and economic growth. Major trends in the forecast period include expanding research on cancer treatment, development of combination therapies, development of pharmaceutical manufacturing, strategic collaborations and partnerships, and clinical trials expansion.
The growing prevalence of chronic diseases is expected to drive the expansion of the CC chemokine receptor type 5 (CCR5) market in the coming years. Chronic diseases are long-term medical conditions, such as heart disease, diabetes, and arthritis, which progress gradually and typically require ongoing management. The rise in chronic diseases can be attributed to aging populations and increasing rates of lifestyle-related risk factors, including poor diet, lack of physical activity, and obesity. CCR5 plays a key role in chronic diseases like human immunodeficiency virus (HIV), acting as a coreceptor that facilitates the virus's entry into immune cells and contributes to the disease's progression. For example, in October 2023, the Joint United Nations Programme on HIV/AIDS, a Switzerland-based global initiative focused on HIV prevention, reported that in 2021, approximately 38.7 million people were living with HIV, with the number rising to 39.0 million in 2022, including 1.3 million new infections that year. Consequently, the increasing prevalence of chronic diseases is fueling the growth of the CCR5 market.
Companies in the CCR5 market are focusing on developing new drugs, such as CCR5 antagonists, to maintain a competitive edge. CCR5 antagonists are medications that block the CCR5 receptor on immune cells, preventing certain pathogens such as HIV from binding and entering these cells, thereby inhibiting infection and influencing immune responses. For instance, in February 2024, CytoDyn Inc., a US-based biotechnology firm, announced that the U.S. Food and Drug Administration (FDA) had lifted the clinical hold on leronlimab, a CCR5 antagonist also known as PRO 140. This approval allows CytoDyn to proceed with its planned clinical trial to evaluate leronlimab's effects on chronic inflammation. Leronlimab shows potential for treating various health conditions, including HIV and cancer, due to its ability to target multiple diseases.
In October 2022, Amgen Inc., a US-based biopharmaceutical company, acquired ChemoCentryx for approximately $3.7 billion. This acquisition is aimed at enhancing Amgen's portfolio in inflammation and nephrology by incorporating ChemoCentryx's innovative therapeutics, such as TAVNEOS (avacopan), into its product lineup. ChemoCentryx is a US-based company specializing in CCR5-related medicines.
Major companies operating in the cc chemokine receptor type 5 market are Pfizer Inc., Sorrento Therapeutics, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Avexa Limited, Thermo Fisher Scientific Inc., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical, Gilead Sciences Inc., Vertex Pharmaceuticals, Ono Pharmaceutical Co Ltd, Abcam Limited, BioLegend Inc., R&D Systems Inc, American Gene Technologies International Inc, NSJ Bioreagents, Cytodyn Inc., Affinity Biosciences
North America was the largest region in the CC chemokine receptor type 5 market in 2024. The regions covered in the cc chemokine receptor type 5 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cc chemokine receptor type 5 market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The CC chemokine receptor type 5 market consists of sales of receptor antagonists, monoclonal antibodies, small molecule inhibitors, and gene editing therapies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
CC Chemokine Receptor Type 5 Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cc chemokine receptor type 5 market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cc chemokine receptor type 5 ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cc chemokine receptor type 5 market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: BMS-813160; AG-1105; CCL-14; DS-001; Other Types
2) By Distribution Channel: Hospitals; Clinics; Online Pharmacies; Retail Pharmacies
3) By Application: Infectious Disease; Gastrointestinal; Immunology; Oncology; Other Applications
4) By End User: Research Institutes; Pharmaceutical Companies; Healthcare Facilities
Subsegments:
1) By BMS-813160: CCR5 Antagonist For HIV Treatment; CCR5 Antagonist For Inflammatory Diseases
2) By AG-1105: CCR5 Antagonist For Autoimmune Disorders; CCR5 Antagonist For Cancer Therapy
3) By CCL-14: Chemokine Ligand For Targeted Therapy; CCL-14 For Immune Modulation
4) By DS-001: CCR5 Inhibitor For Cancer Treatment; DS-001 For Inflammatory Disease Management
5) By Other Types: Novel CCR5 Antagonists; Dual-Target CCR5 Antagonists
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. CC Chemokine Receptor Type 5 Market Characteristics
3. CC Chemokine Receptor Type 5 Market Trends And Strategies
4. CC Chemokine Receptor Type 5 Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global CC Chemokine Receptor Type 5 Growth Analysis And Strategic Analysis Framework
5.1. Global CC Chemokine Receptor Type 5 PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global CC Chemokine Receptor Type 5 Market Growth Rate Analysis
5.4. Global CC Chemokine Receptor Type 5 Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global CC Chemokine Receptor Type 5 Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global CC Chemokine Receptor Type 5 Total Addressable Market (TAM)
6. CC Chemokine Receptor Type 5 Market Segmentation
6.1. Global CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
BMS-813160
AG-1105
CCL-14
DS-001
Other Types
6.2. Global CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Online Pharmacies
Retail Pharmacies
6.3. Global CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Disease
Gastrointestinal
Immunology
Oncology
Other Applications
6.4. Global CC Chemokine Receptor Type 5 Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research Institutes
Pharmaceutical Companies
Healthcare Facilities
6.5. Global CC Chemokine Receptor Type 5 Market, Sub-Segmentation Of BMS-813160, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CCR5 Antagonist For HIV Treatment
CCR5 Antagonist For Inflammatory Diseases
6.6. Global CC Chemokine Receptor Type 5 Market, Sub-Segmentation Of AG-1105, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CCR5 Antagonist For Autoimmune Disorders
CCR5 Antagonist For Cancer Therapy
6.7. Global CC Chemokine Receptor Type 5 Market, Sub-Segmentation Of CCL-14, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chemokine Ligand For Targeted Therapy
CCL-14 For Immune Modulation
6.8. Global CC Chemokine Receptor Type 5 Market, Sub-Segmentation Of DS-001, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CCR5 Inhibitor For Cancer Treatment
DS-001 For Inflammatory Disease Management
6.9. Global CC Chemokine Receptor Type 5 Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Novel CCR5 Antagonists
Dual-Target CCR5 Antagonists
7. CC Chemokine Receptor Type 5 Market Regional And Country Analysis
7.1. Global CC Chemokine Receptor Type 5 Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global CC Chemokine Receptor Type 5 Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific CC Chemokine Receptor Type 5 Market
8.1. Asia-Pacific CC Chemokine Receptor Type 5 Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China CC Chemokine Receptor Type 5 Market
9.1. China CC Chemokine Receptor Type 5 Market Overview
9.2. China CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India CC Chemokine Receptor Type 5 Market
10.1. India CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan CC Chemokine Receptor Type 5 Market
11.1. Japan CC Chemokine Receptor Type 5 Market Overview
11.2. Japan CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia CC Chemokine Receptor Type 5 Market
12.1. Australia CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia CC Chemokine Receptor Type 5 Market
13.1. Indonesia CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea CC Chemokine Receptor Type 5 Market
14.1. South Korea CC Chemokine Receptor Type 5 Market Overview
14.2. South Korea CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe CC Chemokine Receptor Type 5 Market
15.1. Western Europe CC Chemokine Receptor Type 5 Market Overview
15.2. Western Europe CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK CC Chemokine Receptor Type 5 Market
16.1. UK CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany CC Chemokine Receptor Type 5 Market
17.1. Germany CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France CC Chemokine Receptor Type 5 Market
18.1. France CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy CC Chemokine Receptor Type 5 Market
19.1. Italy CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain CC Chemokine Receptor Type 5 Market
20.1. Spain CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe CC Chemokine Receptor Type 5 Market
21.1. Eastern Europe CC Chemokine Receptor Type 5 Market Overview
21.2. Eastern Europe CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia CC Chemokine Receptor Type 5 Market
22.1. Russia CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America CC Chemokine Receptor Type 5 Market
23.1. North America CC Chemokine Receptor Type 5 Market Overview
23.2. North America CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA CC Chemokine Receptor Type 5 Market
24.1. USA CC Chemokine Receptor Type 5 Market Overview
24.2. USA CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada CC Chemokine Receptor Type 5 Market
25.1. Canada CC Chemokine Receptor Type 5 Market Overview
25.2. Canada CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America CC Chemokine Receptor Type 5 Market
26.1. South America CC Chemokine Receptor Type 5 Market Overview
26.2. South America CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil CC Chemokine Receptor Type 5 Market
27.1. Brazil CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East CC Chemokine Receptor Type 5 Market
28.1. Middle East CC Chemokine Receptor Type 5 Market Overview
28.2. Middle East CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa CC Chemokine Receptor Type 5 Market
29.1. Africa CC Chemokine Receptor Type 5 Market Overview
29.2. Africa CC Chemokine Receptor Type 5 Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa CC Chemokine Receptor Type 5 Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa CC Chemokine Receptor Type 5 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. CC Chemokine Receptor Type 5 Market Competitive Landscape And Company Profiles
30.1. CC Chemokine Receptor Type 5 Market Competitive Landscape
30.2. CC Chemokine Receptor Type 5 Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Sorrento Therapeutics Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
31. CC Chemokine Receptor Type 5 Market Other Major And Innovative Companies
31.1. Avexa Limited
31.2. Thermo Fisher Scientific Inc.
31.3. AstraZeneca plc
31.4. Novartis AG
31.5. GlaxoSmithKline plc
31.6. Takeda Pharmaceutical
31.7. Gilead Sciences Inc.
31.8. Vertex Pharmaceuticals
31.9. Ono Pharmaceutical Co Ltd
31.10. Abcam Limited
31.11. BioLegend Inc.
31.12. R&D Systems Inc
31.13. American Gene Technologies International Inc
31.14. NSJ Bioreagents
31.15. Cytodyn Inc.
32. Global CC Chemokine Receptor Type 5 Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The CC Chemokine Receptor Type 5 Market
34. Recent Developments In The CC Chemokine Receptor Type 5 Market
35. CC Chemokine Receptor Type 5 Market High Potential Countries, Segments and Strategies
35.1 CC Chemokine Receptor Type 5 Market In 2029 - Countries Offering Most New Opportunities
35.2 CC Chemokine Receptor Type 5 Market In 2029 - Segments Offering Most New Opportunities
35.3 CC Chemokine Receptor Type 5 Market In 2029 - Growth Strategies
